FindTrial
Sign In

Does Shatavari affect quality of life and reproductive health of females?

Randomized Controlled Trials to evaluate the effects of Shatavari (Asparagus racemosus) on the quality of life and muscle strength of post-menopausal females and women during menstruation alongwith effect on lactation on breastfeeding mothers and muscle strength among males.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042463
Enrollment
200
Registered
2022-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Nihar Ranjan Pradhan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women who have attained menopause Able to take the drug orally and comply with study procedures;

Exclusion criteria

Exclusion criteria: In shock, Consumption of other oral probiotic supplements during the trial; Patients with severe underlying diseases that affects survival, including uncontrolled malignant tumor with multiple metastases that cannot be resected, Blood diseases, Dyscrasia, Active bleeding, Severe malnutrition Patients allergic to systemic enzyme supplements; Patients facing imminent death in the opinion of the clinical team; Patients with Hb less than 10 g/dl; Patients who have participated in any other clinical study within 2 weeks prior to randomization

Design outcomes

Primary

MeasureTime frame
Change in score of MENQOL (Menopause-Specific Quality of Life) questionnaire after a 6-week supplementation of ShatavariTimepoint: 6 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactKumar Guru Mishra

AIIMS Bibinagar

drguru1990@gmail.com8984227116

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026